Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.

Moll S, Yasui Y, Abed A, Murata T, Shimada H, Maeda A, Fukushima N, Kanamori M, Uhles S, Badi L, Cagarelli T, Formentini I, Drawnel F, Georges G, Bergauer T, Gasser R, Bonfil RD, Fridman R, Richter H, Funk J, Moeller MJ, Chatziantoniou C, Prunotto M.

J Transl Med. 2018 Jun 1;16(1):148. doi: 10.1186/s12967-018-1524-5.

2.

Growth Differentiation Factor-15 and Risk of CKD Progression.

Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZY, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I, Gadegbeku CA, Gipson D, Hawkins J, Himmelfarb J, Kestenbaum B, Kretzler M, Magnone MC, Perumal K, Steigerwalt S, Ju W, Bansal N.

J Am Soc Nephrol. 2017 Jul;28(7):2233-2240. doi: 10.1681/ASN.2016080919. Epub 2017 Feb 3.

3.

Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.

Bär C, Povedano JM, Serrano R, Benitez-Buelga C, Popkes M, Formentini I, Bobadilla M, Bosch F, Blasco MA.

Blood. 2016 Apr 7;127(14):1770-9. doi: 10.1182/blood-2015-08-667485. Epub 2016 Feb 22.

4.

Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury.

Schley G, Köberle C, Manuilova E, Rutz S, Forster C, Weyand M, Formentini I, Kientsch-Engel R, Eckardt KU, Willam C.

PLoS One. 2015 Dec 15;10(12):e0145042. doi: 10.1371/journal.pone.0145042. eCollection 2015.

5.

Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A, Lai JY, Zhou Y, Hawkins JJ, Bitzer M, Sampson MG, Thier M, Solier C, Duran-Pacheco GC, Duchateau-Nguyen G, Essioux L, Schott B, Formentini I, Magnone MC, Bobadilla M, Cohen CD, Bagnasco SM, Barisoni L, Lv J, Zhang H, Wang HY, Brosius FC, Gadegbeku CA, Kretzler M; ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium.

Sci Transl Med. 2015 Dec 2;7(316):316ra193. doi: 10.1126/scitranslmed.aac7071.

6.

Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction.

Bär C, Bernardes de Jesus B, Serrano R, Tejera A, Ayuso E, Jimenez V, Formentini I, Bobadilla M, Mizrahi J, de Martino A, Gomez G, Pisano D, Mulero F, Wollert KC, Bosch F, Blasco MA.

Nat Commun. 2014 Dec 18;5:5863. doi: 10.1038/ncomms6863.

7.

New renal drug development to face chronic renal disease.

Moll S, Meier M, Formentini I, Pomposiello S, Prunotto M.

Expert Opin Drug Discov. 2014 Dec;9(12):1471-85. doi: 10.1517/17460441.2014.956075. Epub 2014 Sep 6. Review.

PMID:
25195802
8.

Targeting the epithelial cells in fibrosis: a new concept for an old disease.

Moll S, Chaykovska L, Meier M, Budd DC, Formentini I, Pomposiello S, Prunotto M.

Drug Discov Today. 2013 Jun;18(11-12):582-91. doi: 10.1016/j.drudis.2013.01.006. Epub 2013 Jan 22. Review.

PMID:
23348679
9.

The BAR domain protein Arfaptin-1 controls secretory granule biogenesis at the trans-Golgi network.

Gehart H, Goginashvili A, Beck R, Morvan J, Erbs E, Formentini I, De Matteis MA, Schwab Y, Wieland FT, Ricci R.

Dev Cell. 2012 Oct 16;23(4):756-68. doi: 10.1016/j.devcel.2012.07.019. Epub 2012 Sep 13.

10.

From acute injury to chronic disease: pathophysiological hypothesis of an epithelial/mesenchymal crosstalk alteration in CKD.

Prunotto M, Budd DC, Meier M, Formentini I, Hartmann G, Pomposiello S, Moll S.

Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii43-50. doi: 10.1093/ndt/gfs283. Epub 2012 Jul 10. Review.

PMID:
22785113
11.

Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).

Formentini I, Bobadilla M, Haefliger C, Hartmann G, Loghman-Adham M, Mizrahi J, Pomposiello S, Prunotto M, Meier M.

Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii81-8. doi: 10.1093/ndt/gfs270. Epub 2012 Jun 25.

PMID:
22734108
12.

Epithelial-mesenchymal crosstalk alteration in kidney fibrosis.

Prunotto M, Budd DC, Gabbiani G, Meier M, Formentini I, Hartmann G, Pomposiello S, Moll S.

J Pathol. 2012 Oct;228(2):131-47. doi: 10.1002/path.4049. Epub 2012 Aug 20. Review.

PMID:
22570261
13.

Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.

Sumara G, Formentini I, Collins S, Sumara I, Windak R, Bodenmiller B, Ramracheya R, Caille D, Jiang H, Platt KA, Meda P, Aebersold R, Rorsman P, Ricci R.

Cell. 2009 Jan 23;136(2):235-48. doi: 10.1016/j.cell.2008.11.018. Epub 2009 Jan 8.

14.

The N-terminal domain of ERK1 accounts for the functional differences with ERK2.

Marchi M, D'Antoni A, Formentini I, Parra R, Brambilla R, Ratto GM, Costa M.

PLoS One. 2008;3(12):e3873. doi: 10.1371/journal.pone.0003873. Epub 2008 Dec 4.

15.

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.

Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R.

J Biol. 2006;5(5):14. doi: 10.1186/jbiol38.

16.

Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing.

Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, Forti P, Facchini A.

Exp Gerontol. 2003 Jun;38(6):653-9.

PMID:
12814800
17.

Telomere length and telomerase activity: effect of ageing on human NK cells.

Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, Forti P, Facchini A.

Mech Ageing Dev. 2003 Apr;124(4):403-8.

PMID:
12714246
18.

DNA rearrangements in the flagellin locus of an flaA mutant of Campylobacter jejuni during colonization of chicken ceca.

Nuijten PJ, van den Berg AJ, Formentini I, van der Zeijst BA, Jacobs AA.

Infect Immun. 2000 Dec;68(12):7137-40.

Supplemental Content

Loading ...
Support Center